David A. Ricks | Eli Lilly & Co. |
Derica W. Rice | Eli Lilly & Co. |
Philip Johnson | Eli Lilly & Co. |
Enrique A. Conterno | Eli Lilly & Co. |
Michael J. Harrington | Eli Lilly & Co. |
Christi Shaw | Eli Lilly & Co. |
Jeffrey N. Simmons | Eli Lilly & Co. |
Susan Mahony | Eli Lilly & Co. |
Jan M. Lundberg | Eli Lilly & Co. |
Joshua L. Smiley | Eli Lilly & Co. |
Timothy Minton Anderson | Sanford C. Bernstein & Co. LLC |
David R. Risinger | Morgan Stanley & Co. LLC |
Andrew S. Baum | Citigroup Global Markets Ltd. |
Jami Rubin | Goldman Sachs & Co. LLC |
Umer Raffat | Evercore Group LLC |
Tony Butler | Guggenheim Securities LLC |
Marc Goodman | UBS Securities LLC |
Seamus Fernandez | Leerink Partners LLC |
Chris Schott | JPMorgan Securities LLC |
John T. Boris | SunTrust Robinson Humphrey, Inc. |
Gregg Gilbert | Deutsche Bank Securities, Inc. |
Steve Scala | Cowen and Co. LLC |
Vamil K. Divan | Credit Suisse Securities (NYSE:USA) LLC |
Geoffrey Meacham | Barclays Capital, Inc. |
Richard J. Purkiss | Piper Jaffray Ltd. |
Jeffrey Holford | Jefferies LLC |
Alex Arfaei | BMO Capital Markets (United States) |
Ladies and gentlemen, thank you for standing by. Welcome to the Q3 2017 Earnings Conference Call. At this time, telephone lines are in a listen-only mode. Later, there will be an opportunity for questions and answers, with instructions given at that time. [Operation Instructions] And as a reminder, today's conference call is being recorded.